Abbott to Acquire Exact Sciences for $21 Billion

The Wall Street JournalThursday, November 20, 2025 at 3:08:00 PM
Abbott to Acquire Exact Sciences for $21 Billion
  • Abbott is set to acquire Exact Sciences for $21 billion, significantly increasing its footprint in the cancer screening market. This strategic move is aimed at enhancing Abbott's diagnostic offerings and market share.
  • The acquisition is anticipated to strengthen Abbott's position in the healthcare sector, particularly in cancer diagnostics, which is a rapidly growing market. This aligns with Abbott's long-term strategy to diversify its product range and improve patient outcomes.
  • The positive market sentiment surrounding this acquisition reflects investor confidence in Abbott's strategic direction, as evidenced by rising stock prices for both companies amid speculation and discussions about the deal.
— via World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Exact Sciences stock jumps on Abbott Labs acquisition speculation
PositiveFinancial Markets
Exact Sciences' stock experienced a notable increase amid speculation regarding a potential acquisition by Abbott Labs. This surge reflects positive market sentiment surrounding the company's future prospects. Investors are closely monitoring developments as the acquisition talks progress.
Exact Sciences stock jumps on potential acquisition by Abbott
PositiveFinancial Markets
Exact Sciences stock experienced a significant increase following reports of a potential acquisition by Abbott. The news has generated positive sentiment in the markets, reflecting investor confidence in the strategic direction of both companies.
Abbott Labs stock rises on potential Exact Sciences acquisition talks
PositiveFinancial Markets
Abbott Labs' stock has seen an increase due to ongoing discussions regarding a potential acquisition of Exact Sciences. This development has generated positive sentiment in the market, reflecting investor confidence in Abbott's strategic direction.
Abbott nears deal to acquire Exact Sciences stock, William Blair reiterates Outperform
PositiveFinancial Markets
Abbott is reportedly close to finalizing a deal to acquire stock from Exact Sciences, a move that has generated positive sentiment in the markets. William Blair has reiterated its Outperform rating for Abbott, reflecting confidence in the company's strategic direction and potential growth following the acquisition.